The Effect of Short-term Overconsumption of Specific Dietary Nutrients on Liver and Adipose Tissue Metabolism.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 26
- 试验地点
- 2
- 主要终点
- Liver fat
研究概览
简要总结
Despite work showing the overconsumption of saturated fatty acids (SFA) to be metabolically deleterious, debate continues about whether there is a link between SFA and cardiovascular disease risk. To explore this, we are undertaking a human in vivo parallel-design study, comparing two isocaloric high-fat diets; one enriched with SFA and the other enriched with unsaturated fatty acids (UFAs), to determine the impact of dietary fat composition on postprandial metabolism, liver fat, cardiac fat and cardiac function.
详细描述
The investigators will recruit men and women with no medical condition or relevant drug therapy that affects lipid, glucose or liver metabolism.
Purpose and design:
The investigators are asking the research question: "How does the amount and type of fat consumed, influence liver fat content, cardiac function and postprandial fatty acid and liver fat metabolism when someone is not gaining or losing body weight?"
To address this research question investigators want to undertake detail physiological studies, in a parallel dietary intervention, where individuals will have an MRI/S scans to assess liver fat, cardiac fat and cardiac function, along with a postprandial study day to assess how their metabolic response to a experimental test meal, before and then 28 days after consumption of a eucaloric, high fat intervention diet that will be either enriched in saturated or unsaturated fat.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •The participant is willing and able to give informed consent for participation in the study.
- •Male or Female, aged ≥18 or ≤65 years.
- •Body Mass Index ≥19 ≤35 kg/m2
- •No medical condition or relevant drug therapy that is known to affect liver or adipose tissue metabolism.
- •Weight stable for the previous 3 months
排除标准
- •The participant is unwilling or unable to give informed consent for participation in the study. - Aged ≤18 or ≥65 years
- •Body Mass Index ≤19 or ≥35kg/m2
- •Blood haemoglobin <135mg/dL for men and <120mg/dL for women
- •Donated (or lost) ≥250 ml of blood in the previous two months.
- •On a weight loss diet or have decreased their body weight by >5% in the previous 3 months.
- •Have increased their body weight by >5% in the previous 3 months.
- •Any metabolic condition or relevant drug therapy
- •Current smoker
- •History of alcoholism or a greater than recommended alcohol intake (>30 g of alcohol daily for men and >20 g of alcohol daily for women)
- •Haemorrhagic disorders
- •Anticoagulant treatment
- •History of albumin allergy
- •Pregnant or nursing mothers
- •Women prescribed any contraceptive agent or device including oral contraceptives, hormone replacement therapy (HRT) or who have used these within the last 12 months History of severe claustrophobia
- •Presence of metallic implants, pacemakers, or are unwilling to remove any piercings
- •History of an eating disorder or any other psychological condition that may affect the participant's ability to adhere to study intervention/experimental diets.
结局指标
主要结局
Liver fat
时间窗: Pre- and after approx 28 days of consuming interventional diet
Changes in intrahepatic triglyceride, as measured by MRI
次要结局
- Postprandial plasma biochemistry(Pre- and after approx 28 days of consuming interventional diet)